The Current State of Hybrid Coronary Revascularization.

Hybrid coronary revascularization (HCR) combines a minimally invasive surgical approach with percutaneous coronary intervention (PCI) for the treatment of multi-vessel coronary artery disease. Despite decades of use, widespread acceptance has been limited. In this review, we conduct a comparative assessment of HCR in relation to traditional coronary artery bypass graft surgery and multi-vessel PCI. While large scale randomized data is still lacking, numerous studies have demonstrated that HCR may offer benefits regarding resource utilization and short-term morbidity, while delivering comparable mid- and long-term survival compared to traditional bypass surgery. Compared to PCI, HCR may offer similar peri-procedural morbidity, while mitigating the need for repeat revascularization by providing a surgical arterial bypass graft to the left anterior descending artery.